A Suffolk County jury has awarded $8M in favor of Janice Paluzzi, a Massachusetts woman who developed mesothelioma after decades of using Johnson & Johnson’s talcum powder products. The jury found the company liable for negligence and breach of warranty, concluding that the company’s asbestos-contaminated talcum powder products caused Paluzzi’s terminal cancer. J&J ceased production and sale of all products containing talc in the United States in 2020. Ms. Paluzzi was diagnosed with mesothelioma in 2021.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Trump administration weighs crackdown on pharma ads, Bloomberg says
- Johnson & Johnson call volume above normal and directionally bullish
- Johnson & Johnson announces new results from Phase 2 RedirecTT-1 study
- Johnson & Johnson announces clinical data from Phase 1b study of JNJ-4496
- Strategic Positioning and Growth Potential Drive Buy Rating for Johnson & Johnson